 |
인쇄하기
취소
|
SK completed phase III studies for new impotence drug.
SK chemical announced on Aug. 14 that SK-3530, an anti-impotent drug discovered by SK chemical had completed its phase III study.
SK took a joint development of SK-3530 with Intugen, a biotech venture company, since 1998 and completed the phase I study in 2004, the phase II study in Mar. 2005 and the phase III study in Aug. this year very successfully.
The phase III study was performed...
SK took a joint development of SK-3530 with Intugen, a biotech venture company, since 1998 and completed the phase I study in 2004, the phase II study in Mar. 2005 and the phase III study in Aug. this year very successfully.
The phase III study was performed...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.